Test Bank for Pharmacotherapeutics for Advanced Practice: A Practical Approach, 5th Edition by Arcangelo, 9781975160593, Covering Chapters 1-56 | Includes Rationales

Test bank pharmacotherapeutics for advanced practice a
ll ll ll ll ll ll




ll practical approach 5th edition by Virginia P. Arcangelo and
ll ll ll ll ll ll ll ll




ll Peterson Chapters 1-56
ll ll

, TABLE l l OF l l CONTENT

 Chapter 1: Issues l l for l l the l l Practitioner l l in l l Drug l l Therapy

 Chapter 2: Pharmacokinetic ll l l Basis ll ll of ll ll Therapeutics l l l l and ll ll Pharmacodynamic l l


Principles
l l



 Chapter 3: Impact of Drug l l l l l l Interactions l l and l l Adverse l l Events l l on
Therapeutics
l l



 Chapter 4: Principles of ll ll l l Pharmacotherapy ll ll in l l Pediatrics, ll ll Pregnancy ll ll and
Lactation
l l



 Chapter 5: Pharmacotherapy ll ll Principles ll ll in ll ll Older ll ll Adults

 Chapter l l 6: l l Principles l l of l l Antimicrobial l l Therapy

 Chapter l l 7: l l Pharmacogenomics

 Chapter l l 8: l l The l l Economics l l of l l Pharmacotherapeutics

 Chapter l l 9: l l Principles l l of l l Pharmacology l l in l l Pain l l Management

 Chapter l l 10: l l Pain l l Management l l in l l Opioid l l Use l l Disorder l l (OUD) l l Patients

 Chapter l l 11: l l Cannabis l l and l l Pain l l Management

 Chapter l l 12: l l Dermatitis

 Chapter l l 13: l l Bacterial, l l Fungal, l l and l l Viral l l Infections l l of l l the l l Skin

 Chapter l l 14: l l Psoriasis

 Chapter l l 15: l l Acne l l Vulgaris l l and l l Rosacea

 Chapter l l 16: l l Ophthalmic l l Disorders

 Chapter l l 17: l l Otitis l l Media l l and l l Otitis l l Externa

 Chapter l l 18: l l Hypertension

 Chapter l l 19: l l Hyperlipidemia

 Chapter l l 20: l l Chronic l l Stable l l Angina l l and l l Myocardial l l Infarction

 Chapter l l 21: l l Heart l l Failure

 Chapter l l 22: l l Arrhythmias

 Chapter l l 23: l l Respiratory l l Infections

 Chapter l l 24: l l Asthma l l and l l Chronic l l Obstructive l l Pulmonary l l Disease

 Chapter l l 25: Gastric, ll ll Functional ll ll and ll ll Inflammatory ll ll Bowel ll ll Disorders

 Chapter l l 26: l l Gastroesophageal l l Reflux l l Disease l l and l l Peptic l l Ulcer l l Disease

 Chapter l l 27: l l Liver l l Diseases

, Chapter 28: Urinary l l Tract l l Infection

 Chapter 29: Prostatic l l Disorders ll ll and l l Erectile ll ll Dysfunction

 Chapter 30: Overactive l l l l Bladder

 Chapter 31: Sexually l l l l Transmitted l l l l Infections

 Chapter 32: Osteoarthritis ll l l and ll ll Gout

 Chapter 33: Osteoporosis

 Chapter 34: Rheumatoid l l l l Arthritis

 Chapter 35: Headaches

 Chapter 36: Seizure ll ll Disorders

 Chapter 37: Alzheimer’s l l l l Disease

 Chapter 38: Parkinson l l l l Disease

 Chapter 39: Major Depressive
l l l l Disorder l l and l l Bipolar
Disorders
l l



 Chapter 40: Anxiety l l Disorders

 Chapter 41: Sleep l l Disorders

 Chapter 42: Attention l l l l Deficit l l l l Hyperactivity l l l l Disorder

 Chapter 43: Substance l l Use l l Disorders

 Chapter 44: Diabetes ll ll Mellitus

 Chapter 45: Thyroid l l and l l Parathyroid l l Disorders

 Chapter 46: Allergies l l and l l Allergic l l Reactions

 Chapter 47: Human l l l l Immunodeficiency l l l l Virus

 Chapter 48: Organ l l Transplantation

 Chapter 49: Pharmacotherapy l l l l for ll l l Select l l l l Thromboembolic l l


Disorders
l l



 Chapter 50: Anemias

 Chapter 51: Immunizations

 Chapter 52: Smoking l l Cessation

 Chapter 53: Weight l l Loss

 Chapter 54: Contraception

 Chapter 55: Menopause

 Chapter 56: Vaginitis

, Chapter 1 Issues for the Practitioner in Drug Therapy
ll ll ll ll ll ll ll ll




MULTIPLE CHOICE ll




1. Nurse practitioner prescriptive authority is regulated by:
ll ll ll ll ll ll


A. The National Council of State Boards of Nursing
ll ll ll ll ll ll ll


B. The U.S. Drug Enforcement Administration
ll ll ll ll


C. The State Board of Nursing for each state
ll ll ll ll ll ll ll


D. The State Board of Pharmacy
ll ll ll ll




Answer: C PTS: 1

2. Physician Assistant (PA) prescriptive authority is regulated by:
ll ll ll ll ll ll ll


A. The National Council of State Boards of Nursing
ll ll ll ll ll ll ll


B. The U.S. Drug Enforcement Administration
ll ll ll ll


C. The State Board of Nursingll ll ll ll


D. The State Board of Medical Examiners
ll ll ll ll ll




Answer: D PTS: 1

3. Clinical judgment in prescribing includes:
ll ll ll ll


A. Factoring in the cost to the patient of the medication prescribed
ll ll ll ll ll ll ll ll ll ll


B. Always prescribing the newest medication available for the disease process
ll ll ll ll ll ll ll ll ll


C. Handing out drug samples to poor patients ll ll ll ll ll ll


D. Prescribing all generic medications to cut costs ll ll ll ll ll ll




Answer: A PTS: 1

4. Criteria for choosing an effective drug for a disorder include:
ll ll ll ll ll ll ll ll ll


A. Asking the patient what drug they think would work best for them
ll ll ll ll ll ll ll ll ll ll ll


B. Consulting nationally recognized guidelines for disease management
ll ll ll ll ll ll


C. Prescribing medications that are available as samples before writing a prescription
ll ll ll ll ll ll ll ll ll ll


D. Following U.S. Drug Enforcement Administration (DEA) guidelines
ll ll ll ll ll ll


for prescribing
ll ll




Answer: B PTS: 1

5. Nurse practitioner practice may thrive under health-care reform due to:
ll ll ll ll ll ll ll ll ll


A. The demonstrated ability of nurse practitioners to control costs and improve
ll ll ll ll ll ll ll ll ll ll


ll patient outcomes ll


B. The fact that nurse practitioners will be able to practice independently
ll ll ll ll ll ll ll ll ll ll


C. The fact that nurse practitioners will have full reimbursement under health-
ll ll ll ll ll ll ll ll ll ll


care reform
ll ll


D. The ability to shift accountability for Medicaid to the state level
ll ll ll ll ll ll ll ll ll ll




Answer: A PTS: 1